Search

Your search keyword '"Sill, A."' showing total 12,318 results

Search Constraints

Start Over You searched for: Author "Sill, A." Remove constraint Author: "Sill, A."
12,318 results on '"Sill, A."'

Search Results

151. Correction to: Integrated genomic analysis reveals actionable targets in pediatric spinal cord low-grade gliomas

152. DNA methylation-based classification of sinonasal tumors

154. Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia

156. Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM

158. Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survival

159. Influential factors for COVID-19 related distancing in daily life: a distinct focus on ego-gram

160. Metabolic profiling of serum and urine in lactating dairy cows affected by subclinical ketosis using proton nuclear magnetic resonance spectroscopy

162. Hadron detection with a dual-readout fiber calorimeter

163. Obesity Paradox and the Effect of NT‐proBNP on All‐Cause and Cause‐Specific Mortality.

164. Participatory science methods to monitor water quality and ground truth remote sensing of the Chesapeake Bay.

165. Is Single LIMA-LAD Bypass Appropriate for OPCAB Training?

166. Treatment response as surrogate to predict risk for disease progression in pediatric medulloblastoma with persistent magnetic resonance imaging lesions after first-line treatment.

167. A Text-Mining Analysis of Research Trends in Animal-Assisted Therapy

172. Nano Security: From Nano-Electronics to Secure Systems.

176. Prognostic impact of functional mitral regurgitation prior to left ventricular assist device implantation

177. Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survival

178. GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types

180. Randomized phase II trial of bevacizumab plus everolimus versus bevacizumab alone for recurrent or persistent ovarian, fallopian tube or peritoneal carcinoma: An NRG oncology/gynecologic oncology group study

181. Heterogeneity within the PF-EPN-B ependymoma subgroup

182. DNA methylation-based classification of central nervous system tumours.

183. Metabolomics comparison of serum and urine in dairy cattle using proton nuclear magnetic resonance spectroscopy

184. Effects of seaweed extracts on in vitro rumen fermentation characteristics, methane production, and microbial abundance

185. Summary and Conclusions

194. Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study

196. Clinical Decision Support System for Guidelines-Based Treatment of Gonococcal Infections, Screening for HIV, and Prescription of Pre-Exposure Prophylaxis: Design and Implementation Study

197. Depletion of TBC1D4 improves the metabolic exercise response by overcoming genetically induced peripheral insulin resistance

198. Depletion of TBC1D4 improves the metabolic exercise response by overcoming genetically induced peripheral insulin resistance

199. Versatile, accessible cross-platform molecular profiling of central nervous system tumors: web-based, prospective multi-center validation

Catalog

Books, media, physical & digital resources